Stockreport

Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights [Yahoo! Finance]

Nkarta, Inc.  (NKTX) 
PDF Additional B-cell mediated autoimmune diseases under consideration for broader clinical investigation of NKX019 Pipeline realignment focuses resources on rapid advanc [Read more]